ClariTrial | Search Clinical Trials

Explore/cancer oncology

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

6,299 results for “cancer oncology” · Recruiting · Phase 3 · Phase 2

Page 1 of 420

Recruiting

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Phase 2B Acute Lymphoblastic Leukemia

Biospecimen CollectionBlinatumomabBone Marrow Biopsy+18 more

National Cancer Institute (NCI)222 participants155 sites · United States, Australia, CanadaCompletes Dec 2030

Compare CT.gov Full analysis →

Recruiting

A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)

Phase 2Colo-rectal Cancer

Cemiplimabcemiplimab plus fianlimabcemiplimab + REGN7075+1 more

NSABP Foundation Inc79 participants9 sites · United StatesCompletes Apr 2029

Compare CT.gov Full analysis →

Recruiting

DOVIPA, a Study Evaluating Efficacy and Safety of DOstarlimab and VItamin D3 With mFOLFIRINOX in PAncreatic Cancer

Phase 2Pancreas Neoplasms

DostarlimabVitamin D3 (Cholecalciferol)mFOLFIRINOX Treatment Regimen+1 more

Hopital Foch35 participants5 sites · FranceCompletes Feb 2028

Compare CT.gov Full analysis →

Recruiting

Study of Pembrolizumab Combined with Chemotherapy in the First Line Therapy for R/M HNSCC in China

Phase 2Head and Neck Squamous Cell Carcinoma

Pembrolizumab combined with Chemotherapy

Yuankai Shi150 participants1 site · ChinaCompletes Aug 2023

Compare CT.gov Full analysis →

Recruiting

A Study Comparing QLS32015 Monotherapy Versus Pomalidomide, Dexamethasone (Pd) or Selinexor, Dexamethasone (Sd) in Participants With Relapsed or Refractory Multiple Myeloma

Phase 3Relapsed or Refractory Multiple Myeloma

QLS32015PomalidomideSelinexor+1 more

Qilu Pharmaceutical Co., Ltd.228 participants1 site · ChinaCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Phase 3Endometrial Cancer

Trastuzumab deruxtecanRilvegostomigPembrolizumab+3 more

AstraZeneca600 participants250 sites · United States, Australia, AustriaCompletes Jan 2029

Compare CT.gov Full analysis →

Recruiting

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

Phase 1Phase 2MTAP-deleted Solid Tumors

BAY 3713372

Bayer450 participants60 sites · United States, Australia, BelgiumCompletes Jun 2029

Compare CT.gov Full analysis →

Recruiting

EUS-RFA PANCARDINAL-1 Trial

Phase 2Pancreatic Ductal Adenocarcinoma (PDAC)

Endoscopic Ultrasound (EUS)-Guided Radiofrequency Ablation (RFA)Neoadjuvant Chemotherapy (NAC)

The University of Texas Health Science Center, Houston60 participants1 site · United StatesCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Lerapolturev (PVSRIPO) in GBM

Phase 2Recurrent Supratentorial Glioblastoma

LerapolturevLomustine Pill

Darell Bigner92 participants1 site · United StatesCompletes Feb 2029

Compare CT.gov Full analysis →

Recruiting

A Phase II Study of Loncastuximab Tesirine as Consolidation Strategy in Patients With LBCL in PR After CAR T-cell Therapy

Phase 2Large B-cell LymphomaLymphoma

Loncastuximab Tesirine

M.D. Anderson Cancer Center30 participants1 site · United StatesCompletes Jan 2030

Compare CT.gov Full analysis →

Recruiting

A Randomized Controlled Trial Evaluating the Feasibility and Preliminary Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Advanced Epithelial Ovarian Cancer

Phase 3Ovarian Cancer

PIPAC

tongweihua60 participants1 site · ChinaCompletes Nov 2027

Compare CT.gov Full analysis →

Recruiting

Neoadjuvant PD-1 Blockade for Elderly Esophageal Squamous Cell Carcinoma (BLESS)

Phase 2Esophageal Cancer

neoadjuvant anti-PD-1neoadjuvant anti-PD-1 with LDRT

Shanghai Chest Hospital60 participants1 site · ChinaCompletes May 2025

Compare CT.gov Full analysis →

Recruiting

Real-world Study of Darafenib or Trametinib and Clofarabine for High-risk/Recurrent/Refractory Langerhans Cell Histiocytosis in Children

Phase 2Langerhans Cell Histiocytosis (LCH)

Dabrafenib or Trametinib and Clofarabine

West China Second University Hospital20 participants1 site · ChinaCompletes Jun 2028

Compare CT.gov Full analysis →

Recruiting

Botulinum Toxin A for the Treatment of Chemotherapy Induced Peripheral Neuropathy

Phase 2Peripheral Neuropathy Due to Chemotherapy

IncobotulinumtoxinA (Xeomin®, Merz) (INA)Normal saline

Medical College of Wisconsin40 participants1 site · United StatesCompletes Dec 2023

Compare CT.gov Full analysis →

Recruiting

Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease

Phase 2Metastatic Castration-Resistant Prostate CarcinomaStage IVB Prostate Cancer AJCC v8

Biospecimen CollectionBone ScanComputed Tomography+5 more

University of Washington51 participants3 sites · United StatesCompletes Dec 2027

Compare CT.gov Full analysis →

1–15 of 6,299

Explore/cancer oncology

Status

Phase

Pre-filtered to show active, later-stage trials with the strongest clinical signal.

6,299 results for “cancer oncology” · Recruiting · Phase 3 · Phase 2

Page 1 of 420

Recruiting

Phase 2B Acute Lymphoblastic Leukemia

Biospecimen CollectionBlinatumomabBone Marrow Biopsy+18 more

National Cancer Institute (NCI)222 participants155 sites · United States, Australia, CanadaCompletes Dec 2030

Compare CT.gov Full analysis →

Recruiting

Phase 2Colo-rectal Cancer

Cemiplimabcemiplimab plus fianlimabcemiplimab + REGN7075+1 more

NSABP Foundation Inc79 participants9 sites · United StatesCompletes Apr 2029

Compare CT.gov Full analysis →

Recruiting

DOVIPA, a Study Evaluating Efficacy and Safety of DOstarlimab and VItamin D3 With mFOLFIRINOX in PAncreatic Cancer

Phase 2Pancreas Neoplasms

DostarlimabVitamin D3 (Cholecalciferol)mFOLFIRINOX Treatment Regimen+1 more

Hopital Foch35 participants5 sites · FranceCompletes Feb 2028

Compare CT.gov Full analysis →

Recruiting

Study of Pembrolizumab Combined with Chemotherapy in the First Line Therapy for R/M HNSCC in China

Phase 2Head and Neck Squamous Cell Carcinoma

Pembrolizumab combined with Chemotherapy

Yuankai Shi150 participants1 site · ChinaCompletes Aug 2023

Compare CT.gov Full analysis →

Recruiting

A Study Comparing QLS32015 Monotherapy Versus Pomalidomide, Dexamethasone (Pd) or Selinexor, Dexamethasone (Sd) in Participants With Relapsed or Refractory Multiple Myeloma

Phase 3Relapsed or Refractory Multiple Myeloma

QLS32015PomalidomideSelinexor+1 more

Qilu Pharmaceutical Co., Ltd.228 participants1 site · ChinaCompletes Dec 2027

Compare CT.gov Full analysis →

Recruiting

Phase 3Endometrial Cancer

Trastuzumab deruxtecanRilvegostomigPembrolizumab+3 more

AstraZeneca600 participants250 sites · United States, Australia, AustriaCompletes Jan 2029

Compare CT.gov Full analysis →

Recruiting

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

Phase 1Phase 2MTAP-deleted Solid Tumors

BAY 3713372

Bayer450 participants60 sites · United States, Australia, BelgiumCompletes Jun 2029

Compare CT.gov Full analysis →

Recruiting

EUS-RFA PANCARDINAL-1 Trial

Phase 2Pancreatic Ductal Adenocarcinoma (PDAC)

Endoscopic Ultrasound (EUS)-Guided Radiofrequency Ablation (RFA)Neoadjuvant Chemotherapy (NAC)

The University of Texas Health Science Center, Houston60 participants1 site · United StatesCompletes Dec 2026

Compare CT.gov Full analysis →

Recruiting

Lerapolturev (PVSRIPO) in GBM

Phase 2Recurrent Supratentorial Glioblastoma

LerapolturevLomustine Pill

Darell Bigner92 participants1 site · United StatesCompletes Feb 2029

Compare CT.gov Full analysis →

Recruiting

A Phase II Study of Loncastuximab Tesirine as Consolidation Strategy in Patients With LBCL in PR After CAR T-cell Therapy

Phase 2Large B-cell LymphomaLymphoma

Loncastuximab Tesirine

M.D. Anderson Cancer Center30 participants1 site · United StatesCompletes Jan 2030

Compare CT.gov Full analysis →

Recruiting

A Randomized Controlled Trial Evaluating the Feasibility and Preliminary Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Advanced Epithelial Ovarian Cancer

Phase 3Ovarian Cancer

PIPAC

tongweihua60 participants1 site · ChinaCompletes Nov 2027

Compare CT.gov Full analysis →

Recruiting

Neoadjuvant PD-1 Blockade for Elderly Esophageal Squamous Cell Carcinoma (BLESS)

Phase 2Esophageal Cancer

neoadjuvant anti-PD-1neoadjuvant anti-PD-1 with LDRT

Shanghai Chest Hospital60 participants1 site · ChinaCompletes May 2025

Compare CT.gov Full analysis →

Recruiting

Real-world Study of Darafenib or Trametinib and Clofarabine for High-risk/Recurrent/Refractory Langerhans Cell Histiocytosis in Children

Phase 2Langerhans Cell Histiocytosis (LCH)

Dabrafenib or Trametinib and Clofarabine

West China Second University Hospital20 participants1 site · ChinaCompletes Jun 2028

Compare CT.gov Full analysis →

Recruiting

Botulinum Toxin A for the Treatment of Chemotherapy Induced Peripheral Neuropathy

Phase 2Peripheral Neuropathy Due to Chemotherapy

IncobotulinumtoxinA (Xeomin®, Merz) (INA)Normal saline

Medical College of Wisconsin40 participants1 site · United StatesCompletes Dec 2023

Compare CT.gov Full analysis →

Recruiting

Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease

Phase 2Metastatic Castration-Resistant Prostate CarcinomaStage IVB Prostate Cancer AJCC v8

Biospecimen CollectionBone ScanComputed Tomography+5 more

University of Washington51 participants3 sites · United StatesCompletes Dec 2027

Compare CT.gov Full analysis →

1–15 of 6,299